Lundbeck
HLUN-B.CO
#2650
Rank
A$9.64 B
Marketcap
A$10.16
Share price
-0.46%
Change (1 day)
11.89%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): A$0.93

According to Lundbeck's latest financial reports the company's current EPS (TTM) is A$0.92. In 2024 the company made an earnings per share (EPS) of A$0.66 an increase over its 2023 EPS that were of A$0.51.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$0.9341.01%
2024A$0.6629.29%
2023A$0.5123.09%
2022A$0.4237.26%
2021A$0.30-84.61%
2020A$1.97-24.61%
2019A$2.62-42.06%
2018A$4.5240.7%
2017A$3.21146.26%
2016A$1.30-120.48%
2015A-$6.363231.32%
2014A-$0.19-115.78%
2013A$1.21-23.36%
2012A$1.58-48.01%
2011A$3.04-9.68%
2010A$3.3613.72%
2009A$2.9624.32%
2008A$2.38-6.05%
2007A$2.5381.77%
2006A$1.39-16.76%
2005A$1.67-17.58%
2004A$2.03